Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Breast Cancer Liquid Biopsy Testing Devices Market: Current Analysis and Forecast (2023-2030)
... monitor cancer. Unlike traditional tumor biopsies, which can be invasive and risky, liquid biopsy is less invasive and can provide valuable information about the cancer without the need for a tissue sample. In the context ... Read More
-
Colorectal Cancer Screening and Diagnostic Market - A Global and Regional Analysis: Focus on Type, End User, and Country Analysis - Analysis and Forecast, 2023-2033
... global colorectal cancer screening and diagnostic market was valued at $15.28 billion in 2022 and is expected to reach $28.52 billion by 2033, growing at a CAGR of 5.93% during the forecast period 2023-2033. The ... Read More
-
Viral Vector Production Market By Viral Vector Type (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors), By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Opportunity Analysis and Industry Forecast, 2023-2032 The viral vector production market was valued for $1.1 billion in 2022 and is estimated to reach $6.1 billion by 2032, exhibiting a CAGR of 18.8% from 2023 to ... Read More
-
Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... Esophageal cancer, also known as esophagus cancer, develops in the cells that line the esophagus and occurs when a malignant tumor arises in the esophagus lining. In 2022, the market size of Esophageal Cancer (EC) ... Read More
-
Personalized Cancer Medicine Market By Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics), By End User (Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... billion in 2022 and is estimated to reach $507.23 billion by 2032, exhibiting a CAGR of 10.9% from 2023 to 2032. Personalized medicine, also known as precision medicine, refers to an approach in healthcare that ... Read More
-
Breast Cancer Treatment Market: Current Analysis and Forecast (2022-2030)
... immunotherapy, and targeted therapies. The market is driven by the growing incidence of breast cancer cases, technological advancements, and the increasing demand for personalized treatments. For instance, according to World Health Organization, in 2020, there ... Read More
-
Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032
... and Europe In the United States, KRASG12C is present in ~37% of NSCLC cases. The highest rates of KRASG12D, i.e., ~42% and 30%, were found in pancreatic cancer and CRC, respectively Among the approved therapies, ... Read More
-
Nanotechnology Drug Delivery Market By Formulation (Lipid-based nanomedicine, Polymer-based nanomedicine, Nanocrystals, Others), By Application (Oncology and Hematology, Infectious diseases, Orthopedics, Neurology, Urology, Immunology, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... market was valued for $87.5 billion in 2022 and is estimated to reach $209.5 billion by 2032, exhibiting a CAGR of 9.1% from 2023 to 2032. Nanotechnology is a scientific field that involves manipulating matter ... Read More
-
Oncology Drugs Market Covering Lung Cancer Drugs; Pancreatic Cancer Drugs; Breast Cancer Drugs; Prostate Cancer Drugs; Ovarian Cancer Drugs; Colorectal Cancer Drugs; Gastric Cancer Drugs; Kidney Cancer Drugs; Brain Tumor Drugs; Thyroid Cancer Drugs; Skin Cancer Drugs; Bladder Cancer Drugs; Cervical Cancer Drugs; Blood Cancer Drugs; Global Summary 2023
... Cancer Drugs; Bladder Cancer Drugs; Cervical Cancer Drugs; Blood Cancer Drugs; Global Summary 2023 Global oncology drugs market was worth $222.5 billion in 2022. It was the second largest segment within the market accounting for ... Read More
-
Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Multiple Myeloma (Kahler Disease) Clinical trials scenario. This report provides top line data ... Read More
-
Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Muscle Invasive Bladder Cancer Clinical trials scenario. This report provides top line ... Read More
-
Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type (Autologous Stem Cells, Autologous Non-Stem Cells), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, and Others), End User (Hospitals, Ambu
... and Region 2023-2028 Market Overview: The global autologous stem cell and non-stem cell based therapies market size reached US$ 6.73 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.39 Billion ... Read More
-
Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028. Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, ... Read More
-
Cancer Stem Cell Therapy Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Global Acute Myeloid Leukemia Market Size Study & Forecast, By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy, Other Chemotherapies), and Regional Analysis, 2023-2030
... at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Acute Myeloid Leukemia (AML) is a form of blood ... Read More
-
Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User—Global Forecast to 2030
... (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User—Global Forecast to 2030 The global point-of-care diagnostics market is projected to reach $43.1 ... Read More
-
Next-Generation Breast Cancer Diagnostic and Screening Market - A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker, Offering, End User, and Country Analysis - Analysis and Forecast, 2023-2032
... Diagnostic and Screening Market: Industry Overview The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032, witnessing a CAGR of ... Read More
-
2023 Global Forecast for Kidney Cancer Diagnostics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
2023 Global Forecast for Immunotherapy Drugs Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2023 Global Forecast for Lung Cancer Surgery Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Global Thymus Cancer Market - 2023-2030
... is expected to exhibit a CAGR of 5.5% during the forecast period (2023-2030). The key players are adopting strategies such as partnerships, mergers, acquisitions, product approvals, and regional expansion to stand out as strong competitors ... Read More
-
Global mRNA Cancer Vaccines and Therapeutics Market Research Report 2023(Status and Outlook)
... transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements ... Read More
-
Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2023(Status and Outlook)
... cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the ... Read More
-
Global Cancer Vaccines Market Research Report 2023(Status and Outlook)
... Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors' patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are ... Read More
Research Assistance
